Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| Staurosporine | IC50 | 1.8 [1] | |
| 4-Amino-5-(4-Phenoxyphenyl)-7h-Pyrrolo[2,3-D]pyrimidin-7-Yl-Cyclopentane | IC50 | 2.0 [1] | |
| Dasatinib | IC50 | 0.4 [1], 1.0 [2], 3.0 [3], 4.0 [4] | |
| N-(2-Chloro-6-methylphenyl)-2-[(cyclopropylcarbonyl)amino]-1,3-thiazole-5-carboxamide | IC50 | 35.0 [1], 880.0 [2] | |
| 5-(4-Phenoxyphenyl)-7-isopropyl-7H-pyrrolo[2,3-d]pyrimidine-4-amine | IC50 | 1.0 [1], 10.0 [2], 11.0 [3] | |
MLA | "Quest Database™ Tyrosine-protein kinase LCK Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 6 Dec. 2025, https://www.aatbio.com/data-sets/tyrosine-protein-kinase-lck-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 6). Quest Database™ Tyrosine-protein kinase LCK Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/tyrosine-protein-kinase-lck-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |